Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus

Liver International - Tập 29 Số 1 - Trang 113-119 - 2009
Nathalie C. Leite1, Gil F. Salles, Antonio Luis Eiras de Araújo, Cristiane Alves Villela‐Nogueira, Claudia R.L. Cardoso
1Department of Internal Medicine, University Hospital Clementino Fraga Filho, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Tóm tắt

AbstractBackground/Aims: Diabetic patients have an increased prevalence and severity of non‐alcoholic fatty liver disease (NAFLD). We aimed to investigate the prevalence and the factors associated with the presence of ultrasonographic NAFLD in type‐2 diabetic individuals.Methods: In a cross‐sectional design study, 180 type‐2 diabetic patients were submitted to a complete clinical and laboratory evaluation and abdominal ultrasonography for NAFLD detection and grading. Statistical analysis included bivariate tests, analysis of variance (anova, for increasing severity of steatosis) and multivariate logistic regression.Results: The prevalence of ultrasonographic NAFLD was 69.4% [95% confidence interval (CI): 58.3–82.7%]. Patients with NAFLD were more obese, had a higher waist circumference and serum triglyceride and alanine aminotransferase (ALT) levels than those without steatosis. Neither diabetic degenerative complication, nor glycaemic control was associated with liver steatosis. On multivariate analysis, a high serum triglycerides level [>2.82 mmol/L, odds ratio (OR): 3.7–4.1, 95% CI: 1.2–13.3] and a high‐normal ALT level (≥40 U/L, OR: 2.5–2.7, 95% CI: 1.2–5.9) were independently associated with hepatic steatosis, together with either the presence of obesity (OR: 7.1, 95% CI: 3.0–17.0) or of increased waist circumference (OR: 4.8, 95% CI: 1.9–12.2).Conclusions: Type‐2 diabetic patients have a high prevalence of ultrasonographic NAFLD and its presence is associated with obesity, mainly abdominal, hypertriglyceridaemia and high‐normal ALT levels. Non‐alcoholic fatty liver disease in diabetic patients may develop and progress independent of the diabetes progression itself.

Từ khóa


Tài liệu tham khảo

10.1053/gast.2002.33573

10.1111/j.1464-5491.2005.01748.x

10.1055/s-2004-823098

10.1053/jhep.2002.33324

10.2337/dc06-2247

Adams LA, 2005, The histological course of nonalcoholic fatty liver disease, a longitudinal study of 103 patients with sequential liver biopsies, 42, 132

10.1016/S1542-3565(04)00014-X

Angulo P, 2007, The NAFLD fibrosis score, a noninvasive system that identifies liver fibrosis in patients with NAFLD, 45, 846

10.3748/wjg.v13.i10.1579

10.1016/S0002-9343(00)00602-1

10.1111/j.1464-5491.2006.01817.x

10.1001/jama.285.19.2486

Hung KY, 1997, Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients, experience from Taiwan, an endemic area for hepatitis B, 12, 180

10.1053/gast.2002.35354

Bedogni G, 2005, Prevalence of and risk factors for nonalcoholic fatty liver disease, the dionysos nutrition and liver study, 42, 44

10.1111/j.1572-0241.2003.07486.x

10.1016/j.jhep.2006.06.013

10.1381/0960892053923888

10.1056/NEJMra011775

10.1053/jhep.2003.50161

10.1381/0960892053576820

10.1053/jhep.2003.50229

Browning JD, 2004, Prevalence of hepatic steatosis in an urban population in the United States, impact of ethnicity, 40, 1387

10.1016/S0140-6736(01)06042-1

10.1111/j.1572-0241.2005.41583.x

10.1111/j.1440-1746.2004.03312.x

10.1080/00365520500264953

Paradis V, 2001, High glucose and hyperinsulinemia stimulate connective tissue growth factor expression, a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis, 34, 738

Davi G, 1999, In vivo formation of 8‐iso‐prostaglandin f2alpha and platelet activation in diabetes mellitus, effects of improved metabolic control and vitamin E supplementation, 99, 224

Davi G, 2002, Platelet activation in obese women, role of inflammation and oxidant stress, 288, 2008

10.1007/s00125-007-0897-4

10.1136/bmj.321.7258.405

Chen CH, 2006, Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwn, metabolic significance of nonalcoholic fatty liver disease in nonobese adults, 40, 745